News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Chris Labaki: Exploring immunogenomic determinants of exceptional response to ICI in ccRCC
Chris Labaki/X
Jan 10, 2025, 22:28

Chris Labaki: Exploring immunogenomic determinants of exceptional response to ICI in ccRCC

Chris Labaki, Research Associate at Dana-Farber Cancer Institute, shared a post on X about a recent paper by him and colleagues, published in Nature Cancer:

“Happy to share our work out Nature Cancer co-led with Renee Maria Saliby, and Tejas Jammihal, under the outstanding mentorship of David Braun, Toni Choueiri, Eli Van Allen, Sachet Ashok Shukla exploring immunogenomic determinants of exceptional response to ICI in ccRCC.”

“Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma”

Authors: Tejas Jammihal, Renee Maria Saliby, Chris Labaki, David Braun, Sachet Shukla et al.

Chris Labaki: Exploring immunogenomic determinants of exceptional response to ICI in ccRCC

cancer ccRCC Chris Labaki clear cell renal cell carcinoma David Braun Eli Van Allen Nature Cancer OncoDaily Oncology Renee Maria Saliby Sachet Ashok Shukla Sachet Shukla Tejas Jammihal
Special Coverage
Blog
Jan 11, 2025, 07:16
Applications open for the MCCR workshop - EORTC
Blog
Jan 11, 2025, 06:45
Chinmay Jani: Exploring trends in tracheal, bronchial, and lung cancer mortality
Insight
Jan 11, 2025, 06:35
Loay Kassem: Six studies that could change my breast cancer practice based on SABCS 2024
Blog
Jan 11, 2025, 03:11
Esosa Omoregie: I am now a proud member of the Association of Southeastern Biologists
Science
Jan 10, 2025, 22:45
Role of iron in pathophysiology of MDS, in a preclinical model by Ada Antypiuk et al.
Blog
Jan 10, 2025, 22:38
Jaehyuk Choi: I am joining the University of Texas Southwestern
Science
Jan 10, 2025, 22:28
Chris Labaki: Exploring immunogenomic determinants of exceptional response to ICI in ccRCC
Science
Jan 10, 2025, 21:10
Arndt Vogel: TACE combined with lenvatinib and pembrolizumab vs placebo for intermediate HCC
Science
Jan 10, 2025, 20:10
Senthil Kumar: First-Line Therapy for Metastatic Pancreatic Cancer
Blog
Jan 10, 2025, 20:04
Chandandeep Kaur: Everything that you need to know about the basics of cancer science
Insight
Jan 10, 2025, 19:51
Uma Borate: Reducing Clinical Trial Eligibility Barriers for MDS
Science
Jan 10, 2025, 19:44
Hatice Bölek: Does treatment sequencing with cabazitaxel and 177Lu-PSMA-617 impact outcomes in mCRPC?